OB/GYN Malpractice Insurance in New York: A 2026 Premium and Claims Guide

TL;DR. OB/GYN is New York's highest-priced medical specialty for malpractice. At $1M/$3M claims-made limits, annual premium runs from roughly $37K in Rochester to $196K on Long Island, driven by neonatal claim severity, Lavern's Law cancer-discovery extensions, and the state's absence of damage caps. NY OB/GYNs typically need limits above the $1M/$3M floor and a tail reporting period tied to the 7-year Lavern's Law ceiling.

Why OB/GYN rates are the highest in New York medicine

OB/GYN carries both the highest frequency and the highest severity profile of the common medical specialties. Harvard's CRICO Comparative Benchmarking System has consistently ranked obstetrics among the top three specialties by indemnity paid per case, with neonatal-injury allegations producing average severity well into seven figures (CRICO / Harvard RMF, 2023). In New York, no damage cap and a concentrated verdict environment push that severity higher.

The severity stack: claim frequency meets claim size

OB/GYN claim frequency runs above the national physician average because obstetric care involves two patients per encounter, a mother and a fetus, each with independent legal standing. When an adverse outcome occurs, both can file. Frequency alone would not justify the premium level: the severity multiplier is what moves the rate.

Neonatal encephalopathy and cerebral-palsy allegations sit at the top of the severity distribution. A successful plaintiff verdict in a birth-injury case funds a lifetime of care for the child, which can reach eight figures in a major metropolitan venue. The claim also carries minors tolling, so the file stays open until the child reaches 18 plus an additional 2.5-year filing window, with a 10-year outside cap under CPLR 208.

Carriers reserve against that profile. The rate a physician sees is the carrier's expected claim cost divided by the exposure unit, with loading for reinsurance, capital, and expense. In New York, the expected claim cost is driven by downstate verdict history and the statute's long reporting tail.

The NY multiplier: no cap, long tail, nuclear verdicts

Forty percent of US states cap non-economic damages in medical malpractice at a defined dollar amount. New York does not. A Nassau County jury can return a $30 million pain-and-suffering verdict without any statutory reduction, and post-trial remittitur only adjusts awards the trial judge finds to be materially deviating from reasonable compensation. For a birth-injury case with lifetime care needs, that review rarely reduces the verdict to a number that changes the carrier's reserve math.

The long tail compounds the cap absence. Obstetric claims can report up to 18 years after delivery when minors tolling stacks with the 2.5-year CPLR 214-a window. OB/GYN carriers must hold reserves against claims that will not surface for a decade or more, and the time value of money on those reserves builds into current premium.

Why other high-severity specialties price below OB/GYN

Neurosurgery runs above OB/GYN on per-case severity but sits lower on frequency, which produces a slightly lower aggregate rate in most NY carriers. Orthopedic spine surgery carries meaningful severity but benefits from shorter reporting-development windows. General surgery can approach OB/GYN severity on bariatric and oncology work but lacks the minors-tolling multiplier because the patient cohort is adult.

The combination of high frequency, two-patient legal exposure, high severity per paid claim, and the longest effective reporting tail in medicine is unique to obstetrics. That combination, not any single factor, is why NY OB/GYN prices at the top of the specialty ladder.

Which carriers write NY OB/GYN coverage?

Five admitted carriers underwrite most NY OB/GYN placements: MLMIC (a Berkshire Hathaway subsidiary) insuring over 13,000 physicians (MLMIC, 2024); EmPRO, the former Physicians' Reciprocal Insurers, with $190.2M in 2024 gross written premium (Business Wire / EmPRO, 2024); The Doctors Company; MedPro; and Coverys (ProMutual). The statutory MMIP Pool handles physicians declined by the voluntary market.

MLMIC as the volume writer

Medical Liability Mutual Insurance Company has written New York malpractice for more than 45 years and remains the largest OB/GYN writer in the state. Its territory grid, built over decades of NY loss experience, produces the baseline benchmark against which other carriers quote. An MLMIC quote at the published statewide base times the relevant territory factor is the starting point for most OB/GYN placements.

Berkshire Hathaway's 2018 acquisition and the subsequent demutualization converted MLMIC from a mutual to a stock insurer. The capital backing is meaningful for OB/GYN physicians, who need a carrier that can absorb a nuclear verdict without impairment. The ongoing CBMS v. MLMIC litigation over dividend ownership matters for physicians who were employed during the distribution window and whose employers retained the payouts.

EmPRO, The Doctors Company, MedPro, and Coverys

EmPRO competes with MLMIC on service responsiveness and specialty appetite rather than price. Its obstetric book includes several large NYC academic practices and a tail of independent suburban OB/GYN groups. The 87.9% combined ratio in its 2024 results indicates disciplined underwriting and makes it a credible long-term option.

The Doctors Company is the largest physician-owned mutual in the country. In New York, TDC writes primarily employed OB/GYNs at multi-state hospital systems because TDC can deliver consistent limits across state lines that MLMIC and EmPRO cannot. For a single-state solo practice in New York, TDC rarely wins on price against MLMIC.

MedPro, a Berkshire Hathaway sibling to MLMIC, brings national scale and a strong employer-group appetite. Coverys, the successor to ProMutual, writes selectively in New York, with a preference for low-severity OB/GYN books and competitive pricing on the GYN-only physicians who have dropped obstetrics.

The MMIP Pool as placement of last resort

The New York Medical Malpractice Insurance Plan is the statutory residual market. OB/GYNs declined by all voluntary-market carriers, typically because of claim frequency, disciplinary history, or recent high-severity verdicts, are assigned to MMIP. Premium runs at a surcharge to voluntary rates, and the reported basis for assignment is disclosed to the assigned carrier, which affects future underwriting.

For most OB/GYNs, the MMIP is a stop-gap between voluntary-market placements, not a permanent home. A physician placed in MMIP should treat the year as an opportunity to stabilize claim history, complete any risk-management coursework the carrier requires, and submit back to the voluntary market at the earliest renewal. Brokers can help structure that path.

How a multi-carrier submission usually runs

A standard NY OB/GYN submission goes to three to four admitted carriers simultaneously: MLMIC as the incumbent or baseline, EmPRO as the primary competitor, TDC if the physician sits in a multi-state group, and one of MedPro or Coverys as a secondary benchmark. Each carrier issues its own indication, which differs because of territory-factor granularity, scope-rating logic, and credit application.

The quote comparison is rarely decided on headline price alone. Retroactive-date acceptance, excess-layer availability, tail structure (including the Lavern's Law reporting window discussed below), and claims-handling reputation all factor into the final placement. A physician evaluating a $5K premium difference against a better claims operation typically chooses claims operation, and rightly so.

What does OB/GYN malpractice cost across New York zones?

At standard $1M/$3M claims-made limits, NY OB/GYN premium ranges roughly 5x between upstate and Long Island, the widest specialty-level territory spread in US medicine. Rochester, Buffalo, and Syracuse sit near $37K to $62K annually, while Long Island crests near $196K and Manhattan approaches $173K. Tail coverage adds another 150 to 200 percent of the final annual premium on termination, a six-figure one-time cost for downstate practices.

Annual premium and tail estimate by region

Why the downstate premium sits so far above upstate

Territory factor explains most of the spread. MLMIC, EmPRO, and TDC each publish filed grids that assign a multiplier to each geographic zone, and the OB/GYN specialty carries the steepest modifier gradient because obstetric verdicts concentrate in the downstate boroughs and Long Island. The Nassau and Suffolk zone carries the highest single modifier in the NY filed tables.

The gradient is not arbitrary. Loss data from the NYCOURTS verdict database and NPDB paid-claim reports show per-case severity on Long Island obstetric verdicts running consistently above Manhattan and well above upstate zones. Carriers price to the data, and the published territory factor reflects roughly a decade of rolling loss experience weighted to the most recent years.

What the table does not show: individual relativities

Base rate times territory factor produces the filed premium, but the quote a physician receives also reflects individual relativities the published tables cannot capture. A claims-free OB/GYN in a low-volume practice with hospital risk-management credits can price 20 to 30 percent below the table. A high-volume obstetric solo practice with a recent paid claim can price 15 to 25 percent above.

Excess-layer structure also moves the primary quote. An OB/GYN with a firm $5M or $10M excess in place often sees primary credit because the primary carrier's bad-faith-settlement exposure is contained. Hospital affiliation matters for similar reasons: a credentialed OB/GYN at an academic medical center with a strong peer-review process typically qualifies for a facility credit that a solo private practice cannot access.

What drives OB/GYN malpractice claims in New York?

PIAA closed-claim data shows that neurologically impaired infant cases account for approximately 20 percent of OB/GYN indemnity dollars despite representing a smaller share of claim count, and ACOG reports that 77 percent of OB/GYNs have been sued at least once in their career (ACOG, 2022). Five allegation categories dominate the NY severity distribution.

Neonatal encephalopathy and cerebral palsy

Birth-injury allegations sit at the top of the OB/GYN severity stack. Plaintiffs typically allege delayed recognition of fetal distress, failure to perform timely cesarean delivery, improper use of oxytocin, or inadequate neonatal resuscitation. Average indemnity per paid case runs in the multi-million-dollar range, with downstate NY jury verdicts occasionally reaching the tens of millions for the lifetime-care component alone.

The long reporting tail is what makes these claims difficult to reserve. A 2026 delivery can produce a claim filed in 2044 if the minors-tolling window runs to the statutory cap. Carriers reserve at a discount to expected value, so a large verdict can land hard on the current accident-year loss ratio.

Shoulder dystocia and brachial-plexus injury

Shoulder dystocia is an unpredictable obstetric emergency, and brachial-plexus injury, including Erb's palsy, is a known complication. Allegations typically center on excessive traction during delivery, failure to anticipate the dystocia, or improper use of McRoberts and other relieving maneuvers. Severity is lower than full neonatal encephalopathy cases but still well into six figures per paid claim, with a smaller subset reaching seven figures for permanent upper-extremity disability.

Delayed cancer diagnosis

Cervical, breast, uterine, and ovarian cancer diagnoses drive a large share of the GYN side of the book. The allegation is typically delayed follow-up on an abnormal Pap smear, mammography, ultrasound, or biopsy, or failure to recommend appropriate screening for a high-risk patient. Lavern's Law's 7-year discovery window, discussed in detail below, means these claims can surface years after the patient encounter.

For OB/GYNs with well-woman and oncology-screening responsibility, the tail on a delayed-cancer claim is the practical driver of retirement-era coverage planning. A physician retiring in 2026 must plan for claims to report through 2033 on the care delivered in the final practice year.

Missed preeclampsia, eclampsia, and HELLP

Hypertensive disorders of pregnancy generate a smaller claim count than neonatal injuries but produce high severity when maternal morbidity or mortality occurs. Allegations center on failure to diagnose preeclampsia based on blood-pressure trends, failure to escalate to hospital admission, or mismanagement of HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) in the peripartum period.

Maternal-death verdicts in New York can reach eight figures, particularly when the decedent leaves dependent children and the wrongful-death calculation under EPTL 5-4.1 reflects lifetime lost earnings plus loss of parental guidance.

L&D anesthesia and intrapartum complications

Anesthesia complications during labor and delivery, including epidural-related injury and general anesthesia for emergent cesarean, can implicate the OB/GYN even when a separate anesthesia team is on the case. Joint-and-several liability principles under New York law mean an OB/GYN at a high-verdict case can carry indemnity exposure well beyond the obstetric standard-of-care allegation. Our companion analysis on the real cost of a $2M malpractice verdict for a NY physician walks through the mechanics at mid-range severity.

What limits should a NY OB/GYN actually carry?

New York OB/GYNs historically carried a combined $1.3M/$3.9M through the $1M/$3M primary layer plus the state-funded Section 18 Excess layer. With broker advisories reporting Section 18 closed to new enrollment on December 31, 2024, most NYC teaching hospitals now require $2M primary with $5M or $10M excess for obstetric credentialing, and the combined annual cost has shifted meaningfully toward the physician or the employer.

The $1.3M/$3.9M historical combination

For more than two decades, a NY OB/GYN with voluntary-market primary and Section 18 enrollment carried $1.3M per occurrence and $3.9M aggregate at no additional cost beyond the primary premium. The $0.3M and $0.9M increments above the $1M/$3M primary came from Section 18's state-funded second layer, which applied after the primary limits exhausted.

The combination was never enough to absorb a nuclear verdict, but it met most NYC hospital credentialing minimums and provided a meaningful cushion on mid-severity claims. Physicians who trained and credentialed in New York through the 2000s and 2010s structured their careers around these limits, and many employment contracts still reference $1.3M/$3.9M as the baseline obligation.

What changed after Section 18

Broker advisories report the Section 18 Excess Medical Malpractice Program closed to new enrollment on December 31, 2024, with existing enrollees grandfathered. No NY Department of Health primary source confirming the closure has been located, so physicians relying on Section 18 should verify current status before making coverage decisions.

Assuming the reported closure holds, new NY OB/GYNs and physicians moving between jobs now need to buy their excess privately. At current NY excess markets, a $1M excess layer adds roughly 25 to 35 percent to the primary premium for an OB/GYN, and a $5M excess layer adds 50 to 70 percent. The combined cost of $1M/$3M primary plus $5M excess for a Manhattan OB/GYN can run north of $275K annually.

Why NYC teaching hospitals require $2M primary

Most major NYC academic medical centers, including the NYU, Mount Sinai, NewYork-Presbyterian, and Montefiore systems, require $2M primary plus $5M or $10M excess for obstetric privileges. The rationale is straightforward: a neonatal injury verdict against an attending at a $1M primary limit exposes the hospital's vicarious-liability reserves and its own excess tower to the full gap between the attending's primary and the verdict value.

For a physician negotiating a new NYC hospital-based contract, the limit requirement should be an explicit line item. Employers typically fund the full tower for employed physicians but vary on whether contracted attendings receive an employer-funded excess or must procure it independently. Our analysis of occurrence vs claims-made malpractice insurance in New York covers the structure choice that interacts with limits.

When $2M primary plus $5M excess is the better shape

For most NYC-practicing OB/GYNs, a $2M primary layer with a $5M excess tower strikes a better balance than a $1M primary with larger excess. The primary carrier's bad-faith-settlement exposure is more contained, the primary quote often prices with a credit for the firmer excess stack, and mid-range claims in the $2M to $5M zone never touch the excess carrier, which preserves the excess market for true catastrophic events.

Solo and small-group OB/GYNs in upstate markets frequently carry $1M/$3M primary with a $1M or $2M excess. That structure is defensible where loss history is thin and credentialing minimums are lower, but the Lavern's Law tail risk and minors-tolling exposure still argue for at least some excess layer, even in lower-verdict zones.

How does Lavern's Law reshape OB/GYN reporting obligations?

CPLR 214-a requires NY medical-malpractice actions to be filed within 2 years and 6 months of the alleged act or end of continuous treatment. Lavern's Law, the 2018 amendment, adds a discovery rule for cancer and malignant-tumor misdiagnoses, capped at 7 years from the alleged negligence. The amendment reshapes tail-coverage economics for every OB/GYN with cancer-screening responsibility.

The 2.5-year baseline plus Lavern's Law discovery

Under CPLR 214-a, the limitation period runs 2 years and 6 months from the act, omission, or end of continuous treatment. The continuous-treatment doctrine keeps the clock open for the duration of a course of care, which in a long-term OB/GYN relationship can mean years of accumulated exposure within a single limitation window.

Lavern's Law added a discovery rule for cancer misdiagnosis, starting the 2.5-year clock on the date the patient knew or reasonably should have known of the alleged negligence. The absolute cap is 7 years from the alleged act. For an OB/GYN reading mammograms and Pap smears, a 2026 encounter can produce a filed claim in 2033 if the patient's discovery occurs within the window.

What this means for retiring OB/GYNs

The tail coverage a retiring OB/GYN needs should match the Lavern's Law ceiling, not the shorter defaults baked into many employment contracts. A physician retiring in 2026 who was still practicing in 2024 can face a reporting window that extends to 2031 for cancer claims on 2024 care, and to 2033 for cancer claims on 2026 care. A 5-year defined tail bought on the 2026 termination ends in 2031, which is two years short of the 2033 Lavern's Law ceiling.

The drafting fix is a two-line amendment to the employment-contract tail clause: extend the reporting period to at least 7 years for physicians in specialties with cancer-diagnosis exposure, and reference CPLR 214-a discovery-rule language so future amendments track automatically. Our detailed treatment of tail coverage and when it is required covers the mechanics.

Policy implications for claims-made carriers

Claims-made policies respond only to claims reported while the policy is active or within an extended reporting endorsement. A physician who lets a claims-made policy lapse without tail has no coverage for a Lavern's Law claim that surfaces after the lapse, even though the underlying care occurred during the active policy period. This is the single most expensive structural gap in NY OB/GYN coverage, and the one most commonly missed during a job change or retirement.

Carriers reserve against the Lavern's Law tail, but the physician's own coverage runs only as long as the tail endorsement runs. The alignment between reserve and coverage is the physician's contractual responsibility, not the carrier's. For OB/GYNs who left their last insured position before 2018, Lavern's Law's retroactive application to existing claims under the enactment's effective-date language is a separate issue worth reviewing with counsel.

Which malpractice allegations get reported to the NPDB?

The National Practitioner Data Bank receives a report on every medical-malpractice payment made on behalf of a physician, and the reporting thresholds and downstream credentialing effects are structured under the Health Care Quality Improvement Act of 1986 (NPDB, 2024). For OB/GYNs, the NPDB trail affects future credentialing, licensing, and carrier-appetite decisions well beyond the closed claim itself.

What triggers an NPDB report for an OB/GYN

Any medical-malpractice payment, regardless of dollar amount, made by a carrier or a self-insured entity on behalf of a named physician triggers a mandatory NPDB report. The report includes the physician's name, the payment amount, the allegation category, and a narrative description. Payments made directly by the physician in a personal capacity, not through an insurance or corporate entity, are not reportable, which is a narrow exception that rarely applies in practice.

The timing is also strict: a report must be filed within 30 days of the payment. Settlements structured to avoid a named-physician payment, for example by settling against the hospital or practice entity and not the physician individually, have long been a subject of NPDB-circumvention scrutiny, and plaintiffs' counsel often resist such structuring in a NY settlement.

Top OB/GYN allegation categories in the NPDB

Federal OB/GYN payment data consistently shows four allegation categories dominating: obstetrics-related (neonatal injury, fetal monitoring failure, delivery complications), diagnosis-related (missed or delayed diagnosis, most commonly cancer), surgery-related (intraoperative injury, post-operative complications, wrong-site or wrong-patient events), and treatment-related (medication errors, failure to treat, improper management of a known condition).

Obstetric allegations drive the largest dollar volume; diagnostic allegations drive a large share of the count on the GYN side; and surgery-related allegations carry the highest per-case severity in the non-obstetric category. An OB/GYN's NPDB profile typically reflects the scope of practice, with high-volume L&D physicians seeing obstetric allegations dominate and GYN-only physicians seeing diagnostic and surgical allegations.

Credentialing and carrier-appetite downstream effects

An NPDB report travels with the physician for the life of the career. Every hospital credentialing renewal, every state-license renewal, and every carrier submission queries the NPDB as part of standard due diligence. A single paid claim does not end a career, but a pattern of paid claims within a five-year rolling window typically triggers voluntary-market declinations and MMIP Pool placement.

Carriers weight recent paid claims more heavily than older ones, and the specific allegation category matters. A paid diagnostic-delay claim is typically less punitive at renewal than a paid obstetric-injury claim, because the severity profile on the latter is materially higher. OB/GYNs with a paid claim in the last three years should expect carrier underwriting questions, a likely scope-rating review, and potential premium increase at renewal.

Why the NPDB trail matters for NY OB/GYNs specifically

New York's higher-than-average paid-claim frequency means more OB/GYNs carry NPDB reports than in most states. The downstream effect is a tighter voluntary-market appetite and a more active MMIP Pool. For a NY OB/GYN with one or more paid claims, the broker submission strategy differs meaningfully from a clean-history submission: more carriers on the submission, more detailed narrative and risk-management documentation, and often more lead time before the renewal date to allow for MMIP-adjacent placement decisions.

For context on the broader market this guide sits within, review our companion pillar on NY medical malpractice insurance for all specialties, our orthopedic surgery malpractice coverage in New York guide, and our general surgery malpractice pricing in NY analysis. Service and industry context for OB/GYNs lives on the professional liability coverage page and the physicians industry overview.

Before you bind or renew

OB/GYN malpractice in New York rewards careful structure: the right carrier on the submission, the right primary and excess limits for your credentialing obligations, the right retroactive date on a carrier switch, and a tail reporting period that matches the Lavern's Law ceiling rather than a shorter default. A 30-minute conversation with a broker appointed across MLMIC, EmPRO, TDC, MedPro, and Coverys is usually the most useful hour in the placement process. When you are ready, you can request a quote or schedule a consultation to walk through the specifics for your practice.